4//SEC Filing
Trimarchi Thomas 4
Accession 0000950170-24-135982
CIK 0001743881other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:00 PM ET
Size
5.2 KB
Accession
0000950170-24-135982
Insider Transaction Report
Form 4
Trimarchi Thomas
President and COO
Transactions
- Award
Common Stock
2024-12-10+50,000→ 427,987 total
Footnotes (2)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSU's have no expiration date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0002030813
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 7:00 PM ET
- Size
- 5.2 KB